
    
      The primary endpoint will be the highlight of a quantitative reduction of double positive T
      cells (CD4 + / CD8 +) the specific F prausnitzii peripheral blood in patients with allergic
      asthma, allergic rhinitis and atopic dermatitis compared to samples from a control sample
      collection made available by the laboratory BIOFORTISÂ® located near Nantes University of
      Nantes.
    
  